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Introduction
Angiosarcoma (AS) is a rare vascular malignancy 
accounting for <2% of all soft tissue sarcomas. 
Although AS can originate from any anatomic site, 
>50% are primary to the skin, with the remainder 
arising in deep soft tissue and viscera [1-4]. 
Cutaneous angiosarcomas (cAS) typically occur in 
three distinct clinical settings: cAS associated with 
chronic lymphedema (Stewart-Treves syndrome), 
post-radiation cAS, and most commonly, idiopathic 
(sporadic) cAS of the head and neck. Idiopathic cAS 
classically presents as an asymptomatic enlarging 
bruise-like plaque on the scalp or face of elderly men, 
but it may be more nodular and resemble benign 
or malignant neoplasms or various inflammatory 
disorders [1]. The prognosis for AS is poor, with 
overall survival ranging from 10-54% depending 
upon the site of the primary [1-4]. Similar to other 
sarcomas, the most common site for metastases is 
lung, followed by liver, bone, soft tissue, and lymph 
nodes [2]. Brain metastases are rare, with the majority 
of cases related to primary cardiac AS. True brain 
metastases from cAS, as opposed to direct extension, 
are exceptionally rare and only a few isolated cases 
have been reported [5, 6].
Case Synopsis
A 43-year-old retired radar operator presented with a 
three-month history of an enlarging 3 cm violaceous 
nodule on his left cheek that he first noticed after 
cutting himself shaving (Figure 1A, B). His primary 
care provider initially suspected a furuncle because 
he had similar lesions in the past. Incision and 
drainage were performed, followed by a course of 
sulfamethoxazole/trimethoprim and a triamcinolone 
injection. When the lesion failed to respond, punch 
biopsies were obtained, which showed an infiltrative 
dermal proliferation comprised of pleomorphic 
endothelial cells that formed irregular anastomosing 
vascular channels and diffusely stained with 
CD31, consistent with cAS (Figure 2). While 
awaiting definitive excision, he developed severe 
headaches and left-sided weakness. A right parietal 
intraparenchymal hemorrhagic mass suggestive of 
metastatic AS was seen on head CT (Figure 1C) and 
pulmonary metastases were later identified. The 
patient underwent right parietal craniotomy and 
then resection of the enlarging 6.5 cm facial cAS, 
followed by dorsocervical flap reconstruction and 
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Cutaneous angiosarcomas are rare but typically 
occur in three distinct clinical settings and are most 
commonly found on the scalp or face of elderly men. 
Positive prognostic factors include tumor size less 
than 5 cm, primary tumor location below the head, 
negative margins after excision, resectability, and 
younger age. Metastases drastically reduce survival 
and the most common metastatic site is lung. We 
present a 43-year-old man who had primary cutaneous 
angiosarcoma that initially mimicked a furuncle and 
eventuated in multiple metastases. The metastatic 
disease included brain involvement, which has rarely 
been reported, especially in a relatively young person 
without known predisposing conditions. This unique 
case also highlights the need for early diagnosis 
followed by advanced imaging, given the limitations 
of current therapies and high metastatic potential of 
angiosarcoma.
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whole-brain radiation. The patient then received 
three cycles of paclitaxel but had metastases to his 
right atrium and expired nine months after his initial 
diagnosis.
Discussion
Most cAS arise in elderly men on chronically sun-
damaged or, less commonly, prior irradiated skin 
with a median age at diagnosis of 71 years [3]. Other 
AS risk factors include chronic lymphedema and 
exposure to polyvinyl chloride, thorium chloride, 
arsenic, and radium, which are primarily associated 
with hepatic AS [4].
Contrary to other soft tissue sarcomas, histologic 
grading of AS is not useful in predicting outcome. 
Therefore, all AS are classified as high-grade 
malignancies [2]. Prognostic factors associated with 
worse clinical outcome include patient age >70, 
tumor size >5 cm, tumor stage III or IV, head and 
neck primaries, positive surgical margins, and failure 
to use multimodal therapy [1-4]. Median survival is 
approximately 25.2 months, but this is dramatically 
reduced to 2-6 months if metastases are present [2, 4, 
6]. Since prognosis is closely linked to size and degree 
of invasion, early recognition is paramount, but 
diagnosis is often delayed because of lack of clinical 
suspicion and confusion by a broad differential 
diagnosis: furuncle, epidermoid cyst, squamous cell 
carcinoma, pseudolymphoma, cellulitis, erysipelas, 
fungal infection, atypical mycobacterial infection, 
rosacea, dermatitis, insect bite, or hematoma.
Treatment of choice is surgical excision, but cAS 
is notoriously ill-defined and multi-focal, making 
complete resection difficult; the benefit of Mohs is 
unclear. Therefore, adjunctive radiation, or radiation 
alone for poor surgical candidates is commonly 
performed [1-4]. Chemotherapies, primarily 
anthracycline, ifosfamide, and taxanes, are used in 
advanced disease but mostly as palliation. Currently, 
multiple trials are investigating therapies directed 
against VEGF or tyrosine kinases, but survival has not 
improved [2, 4].
Conclusion
This unique case describes a rapidly fatal cAS arising 
in a younger patient with no known predisposing 
risk factors that initially mimicked a furuncle. Owing 
to the high risk of metastatic disease, we concur with 
other authors and recommend advanced radiologic 
imaging upon definitive diagnosis [4].
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Figure 1. Clinical Findings: A and B) Side and anterior views of the lesion after failed initial management, showing a protuberant 3 cm 
violaceous nodule with eschar on the left cheek. C) Head CT without contrast showing a 3.7 x 6.0 x 4.3 cm intraparenchymal hemorrhage 
of the right parietal lobe associated with surrounding edema and right-to-left midline shift.
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Figure 2. Histopathologic Findings: A) Diffuse replacement of the dermis by an infiltrative and hemorrhagic vasoformative 
proliferation, H&E 20%. B) Complex inter-anastomosing jagged channels, H&E, 40%. C) Vascular channels lined by plump pleomorphic 
hyperchromatic endothelial cells with atypical mitotic figures, H&E 400%. D) CD31 immunohistochemical stain, diffuse positive staining, 
40%. The cells of interest failed to label with cytokeratin, Factor XIIIA, and HHV-8 immunohistochemical stains. Cultures and PAS, GMS, 
and AFB-stained slides all failed to identify an infectious etiology.
